Related Experiment Video
Updated: Jun 9, 2026
09:57
Seeding and Implantation of a Biosynthetic Tissue-engineered Tracheal Graft in a Mouse Model
Published on: April 1, 2019
Tissue engineered human tracheas for in vivo implantation
Silvia Baiguera1, Phillip Jungebluth, Alan Burns
1BIOAIR Lab, Department of General Thoracic and Regenerative Surgery and Intrathoracic Biotransplantation University Hospital Careggi, Largo Brambilla 3, I-50134 Florence, Italy.
Biomaterials
|August 31, 2010
Summary
Researchers have developed a faster method to create tissue-engineered tracheas. This new process yields functional tracheal grafts in approximately three weeks, making them viable for urgent transplantations.
Area of Science:
- Regenerative Medicine
- Biomaterials Science
- Surgical Innovation
Background:
- The first successful clinical transplantation of a tissue-engineered trachea was achieved two years ago.
- However, the graft production time of nearly three months was not feasible for urgent patient needs.
Purpose of the Study:
- To describe and characterize an improved decellularization process for human tracheal scaffolds.
- To reduce the production time of bioengineered tracheas for clinical applications.
Main Methods:
- Histological and molecular biology analyses (quantitative PCR) to confirm complete removal of cellular components and nuclear material.
- Scanning Electron Microscopy (SEM) to assess matrix structural integrity.
- Biomechanical testing to evaluate mechanical properties.
- Immunohistological staining and angiogenic assays (CAM analysis) to assess pro-angiogenic potential.
Main Results:
- The improved decellularization process successfully removed all cellular and nuclear material from human tracheal scaffolds.
- Decellularized matrices retained the hierarchical structures and native mechanical properties of the trachea.
- Scaffolds demonstrated preserved angiogenic factors, exhibited in vitro chemo-active action, and induced significant in vivo angiogenic response.
- Production time for bioengineered tracheal grafts was reduced to approximately three weeks.
Conclusions:
- A rapid and clinically viable method for producing human tracheal bioactive supports has been established.
- These bioengineered tracheal grafts are structurally and mechanically comparable to native tracheas.
- The scaffolds possess chemotactic and pro-angiogenic properties, indicating their potential for successful clinical use in airway replacements.
